Skip to Content
Rating as of

Company Profile

Business Description

Registered in the Netherlands, Mylan is a leading generic drugmaker, with roughly 55 manufacturing and R&D facilities. Although the company was formed in 1961, the company's position as the second- largest generic company was largely attributable to the acquisition of Matrix Laboratories and generics business of Germany-based Merck KGaA. Mylan has a portfolio of more than 7,500 generic, specialty, and over-the-counter active ingredients and medicines and is predominantly recognized for manufacturing the EpiPen (treatment for anaphylaxis), which was acquired through the Merk KGaA transaction.

Contact
Mosquito Way, Building 4, Trident Place
Hatfield, Hertfordshire, AL10 9UL, Netherlands
T +44 1707853000
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type
Employees 35,000

Related